Search results for

* Lehman Brothers has completed one of the most successful French IPOs this year with the sale of stock in bio-tech group Transgene. The offering, which was around 15 times oversubscribed, results in a dual listing for the company on the Nouveau Marché and Nasdaq. Lehman and joint lead manager Credit Suisse First Boston were able to close the deal in the face of heavy oversubscription -- pricing the stock at $14.50, the top of the indicated price range. Some 1.314m GDRs were sold to investors with each receipt representing three shares. The joint leads were joined by Crédit Lyonnais and Lazard Capital Markets as co-managers.

Canada Bank of Montreal and Goldman Sachs Credit Partners LP have completed a $1.8bn facility for Canadian National Railway Co and Grand Trunk Co. The facility is split into a five year $600m revolver and a $480m term loan for Canadian National Railway Co, and a one year $320m term loan and a $400m five year revolver for Grand Trunk Co. Pricing for the loan is based on the company's debt ratings.

Edward Brown has quit as head of distribution in Chase Manhattan's global syndicated finance department in London to join Credit Suisse First Boston. He will be a director in CSFB's syndicated finance and asset distribution team in London where he will report to managing director Grant Johnson and work alongside Charles Bennett. Michael Berry and Christophe Cleve have been appointed global co-heads of leveraged finance within Deutsche Morgan Grenfell's structured finance division. Berry will be based in London, while Cleve will be based in Frankfurt. Both will report to Gavin Lickley, head of structured finance.

9483

THE Portuguese government looks likely to move away from its traditional method of rotating lead managers for privatisation mandates, instead rewarding banks which have performed well in previous sales. Goldman Sachs looks likely to team up with ABN Amro Rothschild and BPI to lead the next sale of stock in Electricidade de Portugal (EdP) while Morgan Stanley and BFE looks front runners for the sale of a further stake in the national cement producer, Cimpor. These banks were involved in the companies' earlier sales.

INVESTORS in some of France's largest and best corporates will be offered new stock in capital increases in the next few weeks. The wave of activity demonstrates that the country's leading industrial groups, in common with their German counterparts, intend to make the most of the current bull market sweeping through continental exchanges. Household names such as Cap Gemini, Lafarge and Latecoere are all set to raise capital from existing investors, but the strength of the Paris market is also inspiring many other smaller cap groups to list shares and raise additional capital on the public markets.

9464

Denmark JP Morgan (co-ordinator) and Den Danske Bank (facility agent) will close general syndication of the $350m seven year multicurrency revolving credit for Tele Danmark early next week. Appetite has been strong from the borrower's core relationship banks and an oversubscription is likely. The final syndicate will be about 10 strong with Danish banks dominating the group.

SBC WARBURG Dillon Read took the UK stockmarket by surprise yesterday (Thursday) with one of the gutsiest block trades of recent months, a £763.8m purchase of stock in cellular phone company Orange. Last night the fate of the deal was hanging in the balance, with a stockmarket slide leaving the bank holding up to 50m of the 193m shares it had bought from British Aerospace,

THE supply of convertible paper continued to build this week, following last week's range of successful deals from high quality issuers. Institutional investors lapped up the opportunity to purchase plain vanilla deals as well as synthetics and exchangeables, and salesmen say that the reception given to these transactions should be more than enough to encourage other banks and corporates to issue more paper. Lead manager Nomura joined forces with co-lead ABN Amro Rothschild and co-manager Robert Fleming to launch a rare UK convertible, a £50m issue for bio-tech group, Scotia.

9460

9513